Takeda Pharmaceutical
TAK
$15.47
Share price
-0.77%
Change (1 day)
11.38%
Change (1 year)
Categories
Takeda Pharmaceutical (TAK) - Total debt
Total debt on the balance sheet as of June 2023 : $32.78 B
According to Takeda Pharmaceutical's latest financial reports the company's total debt is $32.78 B. A company’s total debt is the sum of all current and non-current debts.
Takeda Pharmaceutical - Total debt on balance sheet (from 2008 to 2023)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2023-03-31 | $32.90 B | -7.61% |
| 2022-03-31 | $35.61 B | -15.26% |
| 2021-03-31 | $42.02 B | -10.86% |
| 2020-03-31 | $47.14 B | -9.01% |
| 2019-03-31 | $51.81 B | 458.84% |
| 2018-03-31 | $9.27 B | -9.48% |
| 2017-03-31 | $10.24 B | 49.82% |
| 2016-03-31 | $6.83 B | 12.49% |
| 2015-03-31 | $6.07 B | -27.29% |
| 2014-03-31 | $8.35 B | 41.27% |
| 2013-03-31 | $5.91 B | -12.85% |
| 2012-03-31 | $6.78 B | 3324.73% |
| 2011-03-31 | $0.19 B | -1.42% |
| 2010-03-31 | $0.20 B | 0.69% |
| 2009-03-31 | $0.19 B | 241.96% |
| 2008-03-31 | $58.39 M | -40.8% |
| 2007-03-31 | $98.64 M | -7.69% |
| 2006-03-31 | $0.10 B | -38.11% |
| 2005-03-31 | $0.17 B | 22.94% |
| 2004-03-31 | $0.14 B | 32.03% |
| 2003-03-31 | $0.10 B | 18.81% |
| 2002-03-31 | $89.54 M | -29.56% |
| 2001-03-31 | $0.12 B |
Total debt for similar companies or competitors
| Company | Total debt | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $52.90 B | 61.36% | 🇺🇸 USA |
 Novartis NVS | $28.34 B | -13.57% | 🇨🇭 Switzerland |
 Pfizer PFE | $34.92 B | 6.52% | 🇺🇸 USA |
 Amgen AMGN | $61.54 B | 87.70% | 🇺🇸 USA |
 Sanofi SNY | $22.85 B | -30.30% | 🇫🇷 France |
 Merck MRK | $30.74 B | -6.23% | 🇺🇸 USA |
 GlaxoSmithKline GSK | $27.08 B | -17.38% | 🇬🇧 UK |
 Seagen
SGEN | $91.12 M | -99.72% | 🇺🇸 USA |
 Dr. Reddy's RDY | $0.16 B | -99.50% | 🇮🇳 India |